Hydromorphone Hydrochloride Injection — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Hydromorphone Hydrochloride Injection (injection) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on Nov 1, 2017.

Shortage details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0703-0018-01
Dosage Form
Injection
Presentation
Hydromorphone Hydrochloride, Injection, 10 mg/1 mL (NDC 0703-0018-01)
Initial Posting
Nov 1, 2017

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.